Varghese Bibin, Gustafson Andrew, Chew Erin, Chew Christopher, Frech Tracy, El-Harasis Majd A, Kumar Anupam, Shoemaker Benjamin, Chrispin Jonathan, Mukherjee Monica, Dendy Jeffrey M, Hughes Sean G, Clark Daniel E
Division of Cardiology, Vanderbilt University Medical Center, Nashville, TN, United States.
Department of Medicine, Northwestern University School of Medicine, Chicago, IL, United States.
Int J Cardiol Heart Vasc. 2024 Mar 12;52:101381. doi: 10.1016/j.ijcha.2024.101381. eCollection 2024 Jun.
Cardiovascular disease is the leading cause of morbidity and mortality in patients with autoimmune rheumatic diseases. Much of this may be attributed to systemic inflammation resulting in coronary atherosclerosis and myocarditis. Cardiac magnetic resonance imaging is the gold standard for the evaluation of cardiac structure and function, including tissue characterization, which allows for detection of myocardial edema, inflammation, and fibrosis. Advances in parametric mapping and coronary flow reserve measurement techniques have the potential to change the diagnosis, risk stratification, and management of patients with autoimmune rheumatic diseases. We provide an overview of the current evidence and suggest potential future roles for the use of comprehensive cardiac magnetic resonance in patients with autoimmune rheumatic diseases in the field of cardio-rheumatology.
心血管疾病是自身免疫性风湿性疾病患者发病和死亡的主要原因。其中很大一部分可能归因于全身性炎症导致的冠状动脉粥样硬化和心肌炎。心脏磁共振成像(CMR)是评估心脏结构和功能的金标准,包括组织特征分析,可用于检测心肌水肿、炎症和纤维化。参数映射和冠状动脉血流储备测量技术的进展有可能改变自身免疫性风湿性疾病患者的诊断、风险分层和管理。我们概述了当前的证据,并提出了在心血管风湿病领域将综合心脏磁共振成像用于自身免疫性风湿性疾病患者的潜在未来作用。